Outcomes in hospitalized pediatric patients with systemic lupus erythematosus

Mary Beth F Son1, Victor M Johnson, Aimee O Hersh

  • 1Division of Immunology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115. marybeth.son@childrens.harvard.edu.

Pediatrics
|January 1, 2014
PubMed

Insights

Racial and ethnic disparities impact outcomes for children with childhood-onset systemic lupus erythematosus (SLE). Hispanic patients experienced longer hospital stays and higher mortality, while African American race was linked to ICU admissions and death.

Area of Science:

  • Pediatric Rheumatology
  • Health Disparities Research
  • Systemic Lupus Erythematosus (SLE) Studies

Background:

  • Documented outcome disparities exist in adults with systemic lupus erythematosus (SLE).
  • Limited data are available on sociodemographic factors influencing outcomes in childhood-onset SLE.
  • Understanding these disparities is crucial for improving care in pediatric SLE patients.

Purpose of the Study:

  • To investigate associations between sociodemographic factors and hospital admission volume.
  • To examine the relationship between these factors and hospitalization characteristics.
  • To identify risk factors for poor outcomes in patients with childhood-onset SLE.

Main Methods:

  • Analysis of 10,724 admissions for 2775 patients (aged 3–17 years) with SLE from January 2006 to September 2011 using the Pediatric Health Information System.
  • Descriptive statistics and univariable analyses for demographic characteristics, readmissions, and length of stay.
  • Multivariable logistic regression controlling for covariates to assess risk factors for adverse outcomes.

Main Results:

  • Hispanic patients had longer hospital stays, more readmissions, and higher in-hospital mortality.
  • African American race was significantly associated with intensive care unit (ICU) admission.
  • African American race and Hispanic ethnicity were linked to end-stage renal disease and death.

Conclusions:

  • Race and ethnicity are significantly associated with adverse outcomes in hospitalized children with SLE.
  • Hospital volume and location did not show significant associations with patient outcomes.
  • Further research is necessary to fully understand the complex relationship between sociodemographic factors and poor outcomes in childhood-onset SLE.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
929